Uricosuric action of losartan via the inhibition of urate transporter 1 (URAT 1) in hypertensive patients (Q28289326)

2

0 references

Makoto Hosoyamada

3

0 references

Einosuke Mizuta

4

0 references

Kiyotaka Yanagihara

5

0 references

Kazuhiko Sonoyama

6

0 references

Shinobu Sugihara

7

0 references

Osamu Igawa

8

0 references

Tatsuo Hosoya

9

0 references

Akira Ohtahara

10

0 references

Chiaki Shigamasa

11

0 references

Yasutaka Yamamoto

12

0 references

Haruaki Ninomiya

13

0 references

Ichiro Hisatome

Journal of Clinical Hypertension

14

0 references

language of work or name

English

0 references

publication date

October 2008

0 references

published in

0 references

volume

21

0 references

page(s)

1157-62

0 references

issue

10

0 references

cites work

Renal effects of angiotensin II receptor blockade in normotensive subjects

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.245

Concentration-dependent mode of interaction of angiotensin II receptor blockers with uric acid transporter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.245

Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.245

Identification of a novel voltage-driven organic anion transporter present at apical membrane of renal proximal tubule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.245

Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.245

Effect of losartan versus candesartan on uric acid, renal function, and fibrinogen in patients with hypertension and hyperuricemia associated with diuretics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.245

Renal handling of uric acid in normal and gouty subject: evidence for a 4-component system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.245

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.245

The renal-specific transporter mediates facilitative transport of organic anions at the brush border membrane of mouse renal tubules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.245

Mutations in human urate transporter 1 gene in presecretory reabsorption defect type of familial renal hypouricemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.245

Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.245

Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.245

The impact of serum uric acid on cardiovascular outcomes in the LIFE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.245

Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.245

Pilot study of the uricosuric effect of DuP-753, a new angiotensin II receptor antagonist, in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.245

7 January 2021

Effect of eprosartan and losartan on uric acid metabolism in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.245

7 January 2021

Effect of the angiotensin II receptor antagonist losartan on uric acid and oxypurine metabolism in healthy subjects.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.245

7 January 2021

Molecular identification of a renal urate anion exchanger that regulates blood urate levels

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.245

7 January 2021

Cause of persistent hypouricemia in outpatients

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.245

7 January 2021

The renal mechanism for urate homeostasis in normal man

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.245

7 January 2021

Renal hypouricemia with both drug-insensitive secretion and defective reabsorption of urate: a novel type of renal hypouricemia

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.245

7 January 2021

Rapid detection of R90H mutations in the human urate transporter 1 gene

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.245

7 January 2021

Excess urate excretion correlates with severely acidic urine in patients with renal hypouricemia

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.245

7 January 2021

Hematuria in patients with renal hypouricemia

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.245

7 January 2021

Two cases of persistent hypouricemia associated with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.245

7 January 2021

Renal hypouricemia due to an isolated renal defect of urate transport

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.245

7 January 2021

Status of endothelial dependent vasodilation in patients with hyperuricemia

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.245

7 January 2021

Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.245

7 January 2021